CDKN2B-AS1 and Alzheimer disease: Specifically, ANRIL expression was elevated in AD model cells, and ANRIL suppression ameliorated Aβ-induced neurotoxicity, such as cell activity reduction, apoptosis, and neurite growth inhibition, by targeting miR-25a.